COMP <GO>
MMSI vs MRK // ENTERPRISE SCALE & MARKET CAP
Merit Medical Systems Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: MMSI 4
— MRK 11
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
LAST: $86.24 (-7.66%) • MKT CAP: $5.58B
market-cap
$5.58B
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMSI VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMSI | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.70% | 74.80% | -26.10 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | 20.70% | -12.90 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.1x | 15.3x | +7.80 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 3.87% | 3.42% | +0.45 | MMSI | /fcf-yield <GO> |
| Operating Margin | 12.20% | 34.30% | -22.10 | MRK | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 28.10% | -19.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | 1.30% | +10.50 | MMSI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 5.19 | -0.57 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | MMSI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.60% | +0.10 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.3 | 56.9 | -15.59 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.92 | +0.02 | MMSI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 40.4x | 18.4x | +22.00 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.58B | $361.02B | -$355.44B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMSI REV | MRK REV | MMSI GROSS % | MRK GROSS % | MMSI FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $65.01B | 48.7% | 74.8% | $215.7M | $12.36B |
| FY 2024 | $1.36B | $64.17B | 47.4% | 76.3% | $185.7M | $18.10B |
| FY 2023 | $1.26B | $60.12B | 44.0% | 44.0% | $88.6M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMSI // BETA 0.94
MRK // BETA 0.92